Doxanano

Doxanano is committed to pushing the limits of conventional chemotherapy for patients with solid tumors. Their goal is to significantly increase the selective delivery of chemotherapeutic agents into the tumor whilst dramatically limiting adverse effects on healthy organs. They specialize in harnessing the unique properties of their DXN polymersomes drug delivery platform in combination with the precision of radiotherapy.